Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 8206 to 8220 of 8908 results

  1. Olaparib for treating BRCA mutation-positive HER2-negative metastatic breast cancer after chemotherapy (terminated appraisal) (TA762)

    This guidance has been updated and replaced by NICE technology appraisal guidance 1040.

    Withdrawn guidance

  2. Dapagliflozin for treating chronic kidney disease (TA775)

    This guidance has been updated and replaced by NICE technology appraisal guidance 1075.

    Withdrawn guidance

  3. The clinical effectiveness and cost effectiveness of anakinra for rheumatoid arthritis (TA72)

    This appraisal has been updated and replaced by NICE guideline CG79. 

    Withdrawn guidance

  4. Abiraterone for treating newly diagnosed high-risk hormone-sensitive metastatic prostate cancer (TA721)

    This guidance has been updated and replaced by NICE technology appraisal guidance 1110.

    Withdrawn guidance

  5. Teduglutide for treating short bowel syndrome (terminated appraisal) (TA690)

    This guidance has been updated and replaced by NICE technology appraisal guidance TA804.

    Withdrawn guidance

  6. Olaparib plus bevacizumab for maintenance treatment of advanced ovarian, fallopian tube or primary peritoneal cancer (TA693)

    This guidance has been updated and replaced by NICE technology appraisal guidance 946.

    Withdrawn guidance

  7. Chronic obstructive pulmonary disease in over 16s: diagnosis and management (CG101)

    This guideline has been updated and replaced by NICE guideline NG115.

    Withdrawn guideline

  8. Meningitis (bacterial) and meningococcal septicaemia in under 16s: recognition, diagnosis and management (CG102)

    This guideline has been updated and replaced by NICE guideline NG240.

    Withdrawn guideline

  9. Motor neurone disease: non-invasive ventilation (CG105)

    This guideline has been updated and replaced by NICE guideline 42. 

    Withdrawn guideline

  10. Barrett's oesophagus: ablative therapy (CG106)

    This guidance has been updated and replaced by NICE guideline NG231.

    Withdrawn guideline

  11. Hypertension in pregnancy: diagnosis and management (CG107)

    This guidance has been updated and replaced by NICE guideline NG133

    Withdrawn guideline

  12. Chronic heart failure in adults: management (CG108)

    This guideline has been updated and replaced by NICE guideline NG106.

    Withdrawn guideline

  13. Fertility: assessment and treatment for people with fertility problems (CG11)

    This guideline has been updated and replaced by NICE guideline CG156.

    Withdrawn guideline

  14. Chronic kidney disease: early identification and management of chronic kidney disease in adults in primary and secondary care (CG73)

    This guidance has been updated and replaced by NICE guideline CG182.

    Withdrawn guideline

  15. Surgical site infections: prevention and treatment (CG74)

    This guidance has been updated and replaced by NICE guideline NG125.

    Withdrawn guideline